Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124397222 | 12439722 | 2 | F | 20160725 | 20160606 | 20160728 | EXP | CA-PFIZER INC-2016286351 | PFIZER | NGUYEN, P.. PRESCRIBING CASCADE IN AN ELDERLY WOMAN.. CANADIAN PHARMACISTS JOURNAL. 2016;149(3):122-124 | 71.00 | YR | F | Y | 68.40000 | KG | 20160728 | PH | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124397222 | 12439722 | 1 | PS | FESOTERODINE | FESOTERODINE | 1 | 4 MG, 1X/DAY | 22030 | 4 | MG | QD | ||||||||
| 124397222 | 12439722 | 2 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | 20 MG, 1X/DAY | 18667 | 20 | MG | QD | ||||||||
| 124397222 | 12439722 | 3 | SS | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | UNK | U | 0 | ||||||||||
| 124397222 | 12439722 | 4 | SS | ARIPIPRAZOLE. | ARIPIPRAZOLE | 1 | UNK | U | 0 | ||||||||||
| 124397222 | 12439722 | 5 | SS | BUPROPION. | BUPROPION | 1 | UNK | U | 0 | ||||||||||
| 124397222 | 12439722 | 6 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 124397222 | 12439722 | 7 | C | FENOFIBRATE. | FENOFIBRATE | 1 | UNK | 0 | |||||||||||
| 124397222 | 12439722 | 8 | C | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | UNK | 0 | |||||||||||
| 124397222 | 12439722 | 9 | C | RABEPRAZOLE | RABEPRAZOLE | 1 | UNK | 0 | |||||||||||
| 124397222 | 12439722 | 10 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | UNK | 0 | |||||||||||
| 124397222 | 12439722 | 11 | C | POTASSIUM CITRATE. | POTASSIUM CITRATE | 1 | UNK | 0 | |||||||||||
| 124397222 | 12439722 | 12 | C | HYDROXYZINE | HYDROXYZINEHYDROXYZINE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 124397222 | 12439722 | 13 | C | IBUPROFEN. | IBUPROFEN | 1 | UNK | 0 | |||||||||||
| 124397222 | 12439722 | 14 | C | MONTELUKAST | MONTELUKAST SODIUM | 1 | UNK | 0 | |||||||||||
| 124397222 | 12439722 | 15 | C | ANETHOLE TRITHIONE | 2 | 25 MG, 3X/DAY | 0 | 25 | MG | TID | |||||||||
| 124397222 | 12439722 | 16 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | 2.5 MG, 2X/DAY | 0 | 2.5 | MG | BID | ||||||||
| 124397222 | 12439722 | 17 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | 25 MG, 1X/DAY | 0 | 25 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124397222 | 12439722 | 1 | Hypertonic bladder |
| 124397222 | 12439722 | 2 | Oedema peripheral |
| 124397222 | 12439722 | 15 | Dry mouth |
| 124397222 | 12439722 | 16 | Hypertension |
| 124397222 | 12439722 | 17 | Oedema peripheral |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124397222 | 12439722 | OT |
| 124397222 | 12439722 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124397222 | 12439722 | Balance disorder | |
| 124397222 | 12439722 | Fall | |
| 124397222 | 12439722 | Gait disturbance | |
| 124397222 | 12439722 | Multiple fractures |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |